Finland· FI-REL-REL865

Exprep

A senna glycosides product containing sennosides a+b, registered in Finland by Mundipharma Oy. The same ATC class is registered in 8 of our 19 countries.

ATC A06AB06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedExprepATCA06AB06REGISTER NO.FI-REL-REL865PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Senna glycosides is registered in 8 of 19 countries.

Countries holding a registration under ATC A06AB06 (senna glycosides), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 5 of them publish a price we can compare per daily dose

Senna glycosides · ATC A06AB06

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Sennosides A+B
Manufacturer
Mundipharma Oy
Country
Finland (FI)
ATC code
A06AB06
ATC class
Senna glycosides
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Senna glycosides in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All senna glycosides products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Cyprus · Senna Remedica
  • France · Pursennide
  • United Kingdom (Northern Ireland) · Sennosides 12 Years Plus Crescent Pharma, Sennosides 12 Years Plus Farmak Pharmaceuticals Uk
  • Ireland · Senokot
  • Italy · Pursennid
  • Malta · Senna
  • Norway · Pursennid
  • Portugal · Pursennide
  • Sweden · Pursennid Ex-Lax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/009026c4-871d-4ea7-bb14-1c858a1311ae
GET /v1/drugs/009026c4-871d-4ea7-bb14-1c858a1311ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "15",
  "form": "oraaliliuos",
  "route": null,
  "ddd_unit": "ED",
  "strength": "2 mg/ml",
  "atc_label": "sennaglykosidit",
  "ma_number": "6484",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL865",
  "authorised_at": "1972-12-13"
}

See everything about senna glycosides.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.